Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ)

CNY 4.21

(-0.94%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 5.11 Billion 8.1 Billion 9.49 Billion 7.72 Billion 7.46 Billion 1.4 Billion
Total Current Assets 2.06 Billion 4.72 Billion 6.36 Billion 4.88 Billion 4.87 Billion 817.22 Million
Cash And Short Term Investments 694.99 Million 1.45 Billion 2.01 Billion 1.28 Billion 1.21 Billion 323.35 Million
Cash and Cash Equivalents 692.89 Million 1.43 Billion 2 Billion 1.28 Billion 1.1 Billion 323.35 Million
Short Term Investments 2.1 Million 17.1 Million 12.57 Million -98.98 Million 106.84 Million 83.04 Million
Net Receivables 850.9 Million 2.31 Billion 3.47 Billion 2.83 Billion 2.41 Billion 194.52 Million
Inventory 455.61 Million 684.98 Million 709.07 Million 645.81 Million 740.91 Million 193.22 Million
Other Current Assets 66 Million 269.39 Million 167.21 Million 113.68 Million 502.87 Million 106.13 Million
Total Non-Current Assets 3.04 Billion 3.38 Billion 3.12 Billion 2.84 Billion 2.58 Billion 584.5 Million
Net PPE 1.62 Billion 1.77 Billion 2.07 Billion 1.92 Billion 1.75 Billion 390.2 Million
Good Will And Intangible Assets 703.1 Million 650.84 Million 660.05 Million 610.68 Million 520.24 Million 186.94 Million
Good Will 1.95 Million 4.37 Million 9.75 Million 8.81 Million 6.38 Million 6.38 Million
Intangible Assets 701.15 Million 646.46 Million 650.29 Million 601.87 Million 513.85 Million 186.94 Million
Long-Term Investments 369.54 Million 214.86 Million 52.66 Million 165.64 Million -44.05 Million -28.82 Million
Tax Assets 286.15 Million 417.54 Million 183.66 Million 126.05 Million 136.36 Million 7.35 Million
Other Non Current Assets 61.54 Million 325.4 Million 160.98 Million 17.44 Million 219.1 Million 28.83 Million
Other Assets -0.00 - - - 1.00 -
Total Liabilities 2.45 Billion 4.8 Billion 4.76 Billion 3.37 Billion 3.49 Billion 491.84 Million
Total Current Liabilities 1.91 Billion 4.37 Billion 4 Billion 2.96 Billion 2.95 Billion 247.21 Million
Account Payables 384.89 Million 512.25 Million 899.76 Million 851.52 Million 1.09 Billion 84.06 Million
Tax Payables 1.79 Million 22.59 Million 228.53 Million 237.69 Million 226.47 Million 9.65 Million
Short Term Debt 1.02 Billion 3.26 Billion 2.22 Billion 1.12 Billion 780.88 Million 110 Million
Deferred Revenue 134.28 Million 169.28 Million 864.42 Million 973.39 Million 966.86 Million 9.65 Million
Other Current Liabilities 373.4 Million 428.43 Million 20.63 Million 18.85 Million 108.92 Million 43.49 Million
Total Non Current Liabilities 537.5 Million 426.52 Million 753.76 Million 404.62 Million 547.88 Million 244.62 Million
Long-Term Debt 429.23 Million 253.8 Million 624.26 Million 303.32 Million 463.98 Million 218.45 Million
Deferred Revenue Non Current 89.93 Million 93.58 Million 102.22 Million 101.29 Million 83.9 Million 26.17 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 10.75 Million 79.13 Million 27.27 Million -303.32 Million 463.98 Million 218.45 Million
Other Liabilities 1.00 1.00 1.00 - - 1.00
Total Equity 2.57 Billion 3.3 Billion 4.73 Billion 4.35 Billion 3.96 Billion 1.11 Billion
Stock Holders Equity 2.46 Billion 3.17 Billion 4.38 Billion 4.04 Billion 3.67 Billion 909.88 Million
Common Stock 1.08 Billion 1.08 Billion 1.46 Billion 1.46 Billion 1.43 Billion 200 Million
Retained Earnings 875.21 Million 1.53 Billion 2.78 Billion 2.44 Billion 2.19 Billion 378.02 Million
Accumulated other comprehensive income 40.67 Million 42.73 Million -40.77 Million -66.33 Million 52.45 Million 59.91 Million
Common Stock Equity 2.46 Billion 3.17 Billion 4.38 Billion 4.04 Billion 3.67 Billion 909.88 Million
Capital Lease Obligation 66.09 Million 62.88 Million 57.13 Million 61.54 Million - -
Total Investments 371.64 Million 231.96 Million 65.24 Million 66.65 Million 62.78 Million 54.21 Million
Total Debt 1.52 Billion 3.51 Billion 2.84 Billion 1.42 Billion 1.24 Billion 328.45 Million
Net Debt 827.4 Million 2.08 Billion 844.98 Million 138.69 Million 136.33 Million 5.09 Million

Balance Sheet Charts